Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
Before you try to banish the winter blues by adding some color to your skin with a trip to...
When considering the most common types of cancer, gastric cancer (cancer of the stomach) is rarely discussed. It occurs...
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
On Tuesday, President Barack Obama signed H.R. 34, the 21st Century Cures Act (Cures), into law. The expansive bill...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
This past week has included good news for some patients with lung cancer and bad news for those with...
Genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies revealed multiple alterations...